Why Psychiatry Belongs on the Care Team for Dysautonomia

If you've been diagnosed with POTS, vasovagal syncope, or another form of dysautonomia, there's a decent chance someone told you, at some point before your real diagnosis, that it was "probably just anxiety." That experience is common enough to be documented: in a large survey of POTS patients, 80% reported being misdiagnosed with anxiety or told their symptoms were "all in your head" before receiving an accurate diagnosis.

That history creates an understandable wariness toward psychiatry in the dysautonomia community. But it points to the opposite conclusion from the one it seems to. Good psychiatric care isn't the thing that dismissed these patients. Psychiatry, done correctly and in coordination with cardiology, neurology, and internal medicine, is one of the more underused tools for actually taking dysautonomia patients seriously.

The symptoms genuinely overlap — which is exactly why expertise matters

Dysautonomia and anxiety share a striking amount of physiological overlap: racing heart, lightheadedness, shortness of breath, a sense of dread, difficulty concentrating. That overlap is a two-way street. Autonomic specialists warn that misdiagnosis with a psychiatric disorder, and inappropriate treatment with antidepressants, is common and needs to be avoided unless there's clear evidence of an actual comorbid depressive or anxiety disorder. In other words: a competent psychiatrist's job in this context often starts by ruling anxiety out as the primary explanation, not assuming it in.

But the research also shows real, measurable psychiatric comorbidity does exist in a meaningful subset of dysautonomia patients — it's just more complicated than a simple "your body is fine, it's just stress" story.

Some studies of POTS patients have found no elevated lifetime prevalence of major depression or panic disorder compared to the general population, while other studies using different populations and measures have found POTS patients scoring higher on measures of depression, anxiety, and anxiety sensitivity, with meaningful effects on quality of life and cognition.

Researchers studying this overlap have concluded that psychological morbidity in POTS often appears to be secondary to the underlying autonomic pathology, rather than its cause — meaning the anxiety, when it's present, is frequently a response to living with an unpredictable, disabling illness, not the source of it.

Living with dysautonomia is its own psychiatric risk factor

Even setting aside diagnostic overlap, there's a simpler reason psychiatric support matters for this population: dysautonomia is genuinely hard to live with. It's often invisible to others, frequently disbelieved by providers before diagnosis, unpredictable in its flares, and disruptive to work, relationships, and independence. Chronic illness of that shape is a well-established driver of depression, anxiety, and demoralization — not because the illness is psychiatric in origin, but because being sick in an unpredictable, often-doubted way is genuinely stressful. Addressing that layer isn't optional extra care; it's part of treating the whole patient.

Psychiatric treatment can directly target overlapping symptoms

There's also a pharmacological argument for including psychiatry on the team. Clinicians treating comorbid POTS and conditions like Ehlers-Danlos hypermobility type have pointed out that SSRIs and SNRIs such as venlafaxine and duloxetine are used both for anxiety and depression and as treatment options for POTS symptoms themselves — meaning a well-chosen psychiatric medication can, in the right patient, address mood symptoms and autonomic symptoms at once, rather than requiring providers to treat them as competing diagnoses.

Non-pharmacological psychiatric care matters too. At least one clinical study concluded that psychological interventions may aid recovery and improve adherence to other treatment approaches in POTS patients — worth noting given how demanding dysautonomia treatment regimens (fluid loading, compression garments, graded exercise, medication titration) can be to sustain without support.

What psychiatry should not do here

The flip side of this argument matters just as much: psychiatry is essential alongside proper autonomic workup, not instead of it. Autonomic specialists are explicit that dysautonomia must be clinically suspected and ruled in — through tools like a tilt table test or an in-office stand test — before symptoms get filed under a psychiatric label. A psychiatrist who understands dysautonomia should be functioning as part of a coordinated team with cardiology and neurology, not as the specialist patients get routed to when a workup feels inconclusive or inconvenient.

The bottom line

The right psychiatric involvement in dysautonomia care does two things at once: it takes seriously the real psychological toll of living with a poorly understood, often-dismissed chronic illness, and it protects patients from the exact kind of reductive "it's just anxiety" framing that delayed so many of their diagnoses in the first place. Done well, psychiatry isn't in tension with taking dysautonomia seriously as a physical illness — it's part of what taking it seriously actually looks like.